MedPath

Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.

Not Applicable
Completed
Conditions
Colorectal Cancer
Registration Number
NCT00210106
Lead Sponsor
Institut Bergonié
Brief Summary

The hypothesis is that radiofrequency ablation combined or not with resection may allow a local control (the liver) in patients suffering from unresectable colorectal liver metastases. Patients may have benefit or not from a preoperative (neoadjuvant) chemotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Colorectal cancer Hepatic metastases unresectable by classical surgery Performance status < 2

Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Complete Hepatic Response Rate at 3 Months3 months

Complete hepatic response (CHR) rate was defined as the absence of new hepatic lesions or contrast enhancement at the ablation and resection sites on CT performed at 2 and 3 months. CHR at 3 months was reported

Secondary Outcome Measures
NameTimeMethod
Overall Survivalat 1 and 2 years

OS was defined as the time from the treatment initiation to death due to any cause. Participants without documented death were censored at the date of the last follow-up or last patient contact. The OS was calculated using the product-limit (Kaplan-Meier) method for censored data. 1-year and 2-year OS rate were reported.

Event-free Survivalat 1 and 2 years

Event-free survival was measured from the date of intervention to the date of the first of the following events: initial failure, disease progression (hepatic or distant) or death (all causes). Patients who were alive and event-free were consored at the last documented date of follow-up. 1-year and 2-years EFS rates were reported.

Trial Locations

Locations (12)

CHU d'Angers

🇫🇷

Angers, France

Centre Saint Michel

🇫🇷

Angoulême, France

CHU de Bordeaux

🇫🇷

Bordeaux, France

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

🇫🇷

Bordeaux, France

Hopital Béclère

🇫🇷

Clamart, France

Hopital Sub-Urbain du Bouscat

🇫🇷

Le Bouscat, France

Hopital de la Croix Rousse

🇫🇷

Lyon, France

Hopital Saint Eloi

🇫🇷

Montpellier, France

Centre Hospitalier

🇫🇷

Niort, France

Centre de Radiothérapie et d'Oncologie Médicale

🇫🇷

Pau, France

Scroll for more (2 remaining)
CHU d'Angers
🇫🇷Angers, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.